CEO of Salonpas Maker Seeks to Take the $2.9 Billion Drug Firm Private
Hisamitsu Pharmaceutical Co.’s management is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be worth around ¥450 billion ($2.9 billion), people...
By Hideki Suzuki, Taro Fuse, Kanoko Matsuyama · Bloomberg
Hisamitsu Pharmaceutical Co.’s management is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be worth around ¥450 billion ($2.9 billion), people familiar with the matter said.